Similar articles

• Voriconazole-resistant disseminated Paecilomyces variotii infection in a neutropenic patient with leukaemia on voriconazole prophylaxis.

  Chamilos G, Kontoyiannis DP. Chamilos G, et al. J Infect. 2005 Nov;51(4):e225-8. doi: 10.1016/j.jinf.2005.02.005. J Infect. 2005. PMID: 16291275
• Identification of Paecilomyces variotii in clinical samples and settings.

  Houbraken J, Verweij PE, Rijs AJ, Borman AM, Samson RA. Houbraken J, et al. J Clin Microbiol. 2010 Aug;48(8):2754-61. doi: 10.1128/JCM.00764-10. Epub 2010 Jun 2. J Clin Microbiol. 2010. PMID: 20519470 Free PMC article.
• Combined activity in vitro of caspofungin, amphotericin B, and azole agents against itraconazole-resistant clinical isolates of Aspergillus fumigatus.

  Cuenca-Estrella M, Gomez-Lopez A, Garcia-Effron G, Alcazar-Fuoli L, Mellado E, Buitrago MJ, Rodriguez-Tudela JL. Cuenca-Estrella M, et al. Antimicrob Agents Chemother. 2005 Mar;49(3):1232-5. doi: 10.1128/AAC.49.3.1232-1235.2005. Antimicrob Agents Chemother. 2005. PMID: 15728937 Free PMC article.
• Fatal Scopulariopsis brevicaulis infection in a paediatric stem-cell transplant patient treated with voriconazole and caspofungin and a review of Scopulariopsis infections in immunocompromised patients.

  Steinbach WJ, Schell WA, Miller JL, Perfect JR, Martin PL. Steinbach WJ, et al. J Infect. 2004 Jan;48(1):112-6. doi: 10.1016/s0163-4453(03)00134-8. J Infect. 2004. PMID: 14667801 Review. No abstract available.
• [New developments in antifungal therapy: fluconazole, itraconazole, voriconazole, caspofungin].

  van 't Wout JW, Kuijper EJ, Verweij PE, Kullberg BJ. van 't Wout JW, et al. Ned Tijdschr Geneeskd. 2004 Aug 21;148(34):1679-84. Ned Tijdschr Geneeskd. 2004. PMID: 15453120 Review. Dutch.